Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Quan Emerteq was a medical device component manufacturer, founded in 1998, specializing in single-use medical devices for cardiovascular, neurostimulation, and vascular markets. It was acquired by Greatbatch Inc. in 2007 for $55 million and subsequently combined with Enpath Medical to form Greatbatch's therapy delivery product line.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Quan Emerteq.